In August 1650, 15 women and one man were publicly executed on Newcastle's Town Moor, with their bodies then buried in ...

Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Neuralink is entering a new chapter as Elon Musk announces the launch of its second human trials, marking a major milestone ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...